Metabolic syndrome and bariatric surgery in stone disease etiology

Current Opinion in Urology

Volumn 21, Issue 2, 2011, Pages 129-133

  Tasca, Andrea ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Bariatric surgery; metabolic syndrome; nephrolithiasis; obesity; oxalate nephropathy

Indexed keywords

CALCIUM; CALCIUM OXALATE; PEPTIDE YY;

ARTICLE; BARIATRIC SURGERY; CALCIUM URINE LEVEL; DIABETES MELLITUS; GASTRIC BANDING; HUMAN; HYPEROXALURIA; INSULIN RESISTANCE; JEJUNOILEAL BYPASS; KIDNEY DISEASE; METABOLIC SYNDROME X; NEPHROLITHIASIS; OBESITY; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; STONE FORMATION; UROLITHIASIS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

BARIATRIC SURGERY; HUMANS; HYPEROXALURIA; KIDNEY CALCULI; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 79951681027     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283435cbc     Document Type: Article

References (31)

1. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752. (Pubitemid 41532612)
2. West B, Luke A, Durazo-Arvizu RA, et al. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis 2008; 51:741-747. (Pubitemid 351626247)
3. Rendina D, Mossetti G, De Filippo G, et al. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant 2009; 24:900-906.
4. Negri AL, Spivacow FR, Del Valle EE, et al. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 2008; 36:303-307.
5. Abate N, Chandalia M, Cabo-Chan AV Jr, et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney int 2004; 65:386-392. (Pubitemid 38130632)
6. Duffey BG, Pedro RN, Kriedberg C, et al. Lithogenic risk factors in the morbidly obese population. J Urol 2008; 179:1401-1406.
7. Cappuccio FP, Strazzullo P, Mancini M, et al. Kidneystonesand hypertension: an independent clinical association in a population based study. BMJ 1990; 300:1234-1236. (Pubitemid 20170675)
8. Meydan N, Barutca S, Caliskan S, Camsari T. Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 2003; 37:64-70. (Pubitemid 36246217)
9. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney int 2005; 68:1230-1235. (Pubitemid 43246441)
10. Daudon M,Traxer O, Conort P, et al.Type 2diabetes increasesthe riskforuric acid stones. J Am Soc Nephrol 2006; 17:2026-2033. (Pubitemid 44036187)
11. Danpure CJ. Molecularetiology of primary hyperoxaluria type 1: newdirections for treatment. Am J Nephrol 2005; 25:303-310 (Pubitemid 41202755)
12. Kirkpatrik JR. Jejunoileal bypass. A legacy of late complications. Arch Surg 1987; 122:610-614.
13. Nelson Andersson H, Bosaeus I. Hyperoxaluria in malabsorptive states. Urol Int 1981; 36:1-9. (Pubitemid 11103899)
14. Demaria EJ, Jamal MK. Surgical options for obesity. Gastroenterol Clin North Am 2005; 34:127-142.
15. Sjostrom L, Narro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357:741-752. (Pubitemid 47295641)
16. Asplin JR, Coe FL. Hyperoxaluria in kidney stoneformerstreated with modern bariatric surgery. J Urol 2007; 177:565-569. (Pubitemid 46054037)
17. Dobbins JW, Binder HJ. Effects of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 1976; 70:1096-1100.
18. Borg CM, le Roux CW, Ghatei MA, et al. Progressive rise in gut hormone levels after Roux-en Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006; 93:210-215. (Pubitemid 43259607)
19. Allison MJ, Cook HM, Milne DB, et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986; 116:455-460. (Pubitemid 16115422)
20. Ukleja A, Stone RL. Medical and gastroenterologic management of the postbariatric surgery patient. J Clin Gastroenterol 2004; 38:312-321. (Pubitemid 38393066)
21. Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term conse-quence of Roux-en-Y gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg 2010; 211:8-15.
22. Penniston KL, Kaplon DM, Gould JC, Nakada SF. Gastric band placement for obesity is not associated with increased urinary riskof urolithiasis compared with bypass. J Urol 2009; 182:2340-2346.
23. Nelson WK, Houghton SG, Milliner DS, et al. Enteric hyperoxaluria, nephro-lithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1:481-485.
24. Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney int 2007; 72:100-107. (Pubitemid 47014438)
25. Nasr SH, D' Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008; 3:1676-1683.
26. Patel B, Passman CM, Fernandez A, et al. Prevalence of Hyperoxaluria after bariatric surgery. J Urol 2009; 181:161-166.
27. Malouf NM, Tondapu P, Guth ES, et al. Hypocitraturia after Roux-en-Ygastric bypasssurgery. J Urol 2010; 183:1026-1030.
28. Park AM, Storm DW, Fulmer BF, et al. A prospective study of riskfactors for nephrolithiasis after Roux-en-Y gastric bypass surgery. J Urol 2009; 182:2334-2339.
29. Durrani O, Morrisroe S,Jackman S, et al.Analysisofstonedisease in morbidly obese patientsundergoing gastric bypasssurgery. J Endourol 2006; 20:749-752. (Pubitemid 44736251)
30. Matlaga BR, Shore AD, Magnuson T, et al. Effect of gastric bypass surgery on kidney stone disease. J Urol 2009; 181:2573-2577.
31. Semins MJ, Matlaga BR, Shore AD, et al. The effect of gastric banding on kidney stone disease. Urology 2009; 74:746-749.